Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2021-12-10 00:00:00 ET · period of report 2021-12-08 · accession 0001770252-21-000019 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-10 | 2021-12-08 | MYGN | Lambert Nicole | See Remarks | A - Grant | $0.00 | +10.0K | 174.5K | +6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-08 | A | A | 10,000 | $0.00 | 174,486 | D | — | — | (F2) Includes 317 shares of Myriad common stock that were omitted from the reporting person's Form 3, which was amended to reflect such shares on November 1, 2021. |